SAM #RFI-MCM-TDRFI-BARDA-2026

BARDA RFI: Medical Countermeasures for Drug-Resistant Fungal Infections

BARDA, part of the U.S. Department of Health and Human Services (HHS), is seeking input from organizations involved in antifungal drug development to inform future medical countermeasure acquisitions for drug-resistant fungal infections. - Government Buyer: - Biomedical Advanced Research and Development Authority (BARDA), under the Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS) - Requested Information: - Capabilities, qualifications, and experience in developing medical countermeasures for drug-resistant fungal infections - Open to both Small Businesses (SB) and Other than Small Businesses (OTSB) - Products/Services: - No specific products, part numbers, or quantities requested at this stage - Focus is on gathering market information and capabilities - Unique/Notable Requirements: - Emphasis on drug-resistant fungal infection solutions - Intended to inform future BARDA acquisitions and programs - OEMs and Vendors: - No specific OEMs or vendors named in this RFI - Place of Performance/Contracting Office: - O’NEILL HOUSE OFFICE BUILDING, WASHINGTON, DC 20515

Description

The Center for the Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), is issuing this Request for Information (RFI) to collect feedback from current and prospective antifungal development partners. Information obtained from this RFI will serve as continued planning for potential future acquisitions and programs. The information collected in response to this RFI is intended to strengthen BARDA’s understanding of the current and future marketplace. This notice seeks information from Other than Small Businesses (OTSB) and Small Businesses (SB) regarding their qualifications, experience, and capabilities.

View original listing